Close
  Indian J Med Microbiol
 

Figure 2: Event-free-survival estimate according to Cathepsin L expression in tumor cells in whole Ewing sarcoma family of tumor (ESFT) group (n = 62) (a), in ESFT with localized disease (n = 36) (b), in ESFT with metastatic disease (n = 26) (c). Event-free-survival estimate according to Cathepsin L expression in tumor-associated macrophages in whole ESFT group (n = 62) (d), in ESFT with localized disease (n = 36) (e), in ESFT with metastatic disease (n = 26) (f)

Figure 2: Event-free-survival estimate according to Cathepsin L expression in tumor cells in whole Ewing sarcoma family of tumor (ESFT) group (<i>n</i> = 62) (a), in ESFT with localized disease (<i>n</i> = 36) (b), in ESFT with metastatic disease (<i>n</i> = 26) (c). Event-free-survival estimate according to Cathepsin L expression in tumor-associated macrophages in whole ESFT group (<i>n</i> = 62) (d), in ESFT with localized disease (<i>n</i> = 36) (e), in ESFT with metastatic disease (<i>n</i> = 26) (f)